Donald W. DeGolyer, Director at Emergent BioSolutions Inc. (EBS), sold 17,800 shares at $7.09 ($126K) on 2026-10-07, disclosed to the SEC on 2026-10-07.
Scheduled sale ($126k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EBS | SELL | 2025-08-13 | $136K | — | Filing → |
| EBS | SELL | 2024-11-14 | $273K | — | Filing → |